Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection

NCT ID: NCT02281721

Last Updated: 2021-07-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-03-18

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this observational post-marketing registry will be to collect and analyze safety, effectiveness, and quality of life outcomes, during and after treatment with the Surpass Flow Diverter. Health Economics assessments (cost data) will also be collected and analyzed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a prospective, observational, multi-center, single-arm, post-marketing, international registry with consecutive enrollment of a minimum of 150 patients treated with the Surpass Flow Diverter in accordance with the standard of care at up to 30 registry sites.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single Group; Surpass Flow Diverter(s)

Individuals using the Surpass Flow Diverter(s)

Surpass Flow Diverter(s)

Intervention Type DEVICE

Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surpass Flow Diverter(s)

Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are to be treated with a Surpass Flow Diverter(s) will be eligible to participate in this registry. Patients will be enrolled on a consecutive basis.

Exclusion Criteria

* This is a standard of care registry. Patients should be excluded if standard of care at a given site is such that they are not eligible for treatment with a Surpass Flow Diverter(s).
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stryker Neurovascular

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patrick A Brouwer, MD

Role: PRINCIPAL_INVESTIGATOR

Karolinska Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AZ groeninge

Kortrijk, , Belgium

Site Status

Helsinki University Hospital

Helsinki, , Finland

Site Status

Turun yliopistollinen keskussairaala

Turku, , Finland

Site Status

Hopital Jean Minjoz

Besançon, , France

Site Status

APHP - Kremlin Bicêtre

Le Kremlin-Bicêtre, , France

Site Status

Fondation Rothschild

Paris, , France

Site Status

Hopital Bretonneau

Tours, , France

Site Status

Freiburg University Hospital

Freiburg im Breisgau, , Germany

Site Status

Klinikum Kassel

Kassel, , Germany

Site Status

Universitätsmedizin Mannheim

Mannheim, , Germany

Site Status

San Martino Hospital

Genova, , Italy

Site Status

Neuroradiologia Azienda ILSS9

Treviso, , Italy

Site Status

Radboudumc

Nijmegen, , Netherlands

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital Universitario Marques de Valdecilla

Santander, , Spain

Site Status

Karolinska University Hospital in Solna, Department of Neuroradiology

Stockholm, , Sweden

Site Status

Queen's Hospital of Romford, NHS Barking, Havering and Redbridge University Hospitals Trust

Romford, Essex, United Kingdom

Site Status

Queen Elizabeth Hospital

Birmingham, , United Kingdom

Site Status

The Walton center

Liverpool, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Finland France Germany Italy Netherlands Spain Sweden United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

T4029

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.